Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fusion | 18 | 2024 | 147 | 4.040 |
Why?
|
| Lumbar Vertebrae | 14 | 2024 | 156 | 3.380 |
Why?
|
| Cervical Vertebrae | 10 | 2024 | 107 | 2.190 |
Why?
|
| Diskectomy | 6 | 2023 | 37 | 1.890 |
Why?
|
| Spondylosis | 6 | 2024 | 26 | 1.640 |
Why?
|
| Intervertebral Disc Displacement | 4 | 2019 | 17 | 1.620 |
Why?
|
| Neurosurgical Procedures | 7 | 2016 | 98 | 1.230 |
Why?
|
| Foraminotomy | 2 | 2023 | 2 | 0.960 |
Why?
|
| Patient Reported Outcome Measures | 2 | 2024 | 146 | 0.960 |
Why?
|
| Radiculopathy | 2 | 2023 | 20 | 0.950 |
Why?
|
| Spine | 3 | 2015 | 48 | 0.900 |
Why?
|
| Spinal Diseases | 5 | 2014 | 48 | 0.810 |
Why?
|
| Cost-Benefit Analysis | 9 | 2023 | 308 | 0.770 |
Why?
|
| Disability Evaluation | 4 | 2019 | 214 | 0.770 |
Why?
|
| Spondylolisthesis | 5 | 2022 | 42 | 0.740 |
Why?
|
| Decompression, Surgical | 5 | 2024 | 66 | 0.730 |
Why?
|
| Spinal Stenosis | 3 | 2022 | 26 | 0.720 |
Why?
|
| Brain Injuries | 2 | 2013 | 140 | 0.700 |
Why?
|
| Health Care Costs | 2 | 2013 | 210 | 0.690 |
Why?
|
| Anxiety | 1 | 2024 | 421 | 0.690 |
Why?
|
| Postoperative Complications | 6 | 2021 | 1284 | 0.690 |
Why?
|
| Treatment Outcome | 18 | 2024 | 5591 | 0.660 |
Why?
|
| Low Back Pain | 1 | 2019 | 114 | 0.600 |
Why?
|
| Quality of Life | 8 | 2019 | 1221 | 0.570 |
Why?
|
| Analgesics, Opioid | 2 | 2020 | 533 | 0.560 |
Why?
|
| Costs and Cost Analysis | 3 | 2012 | 102 | 0.560 |
Why?
|
| Neurosurgery | 2 | 2022 | 29 | 0.560 |
Why?
|
| Middle Aged | 26 | 2024 | 17365 | 0.540 |
Why?
|
| Depression | 1 | 2024 | 883 | 0.540 |
Why?
|
| Orthopedic Procedures | 3 | 2015 | 47 | 0.540 |
Why?
|
| Opioid-Related Disorders | 2 | 2020 | 491 | 0.500 |
Why?
|
| Humans | 43 | 2024 | 62682 | 0.470 |
Why?
|
| Aged | 19 | 2024 | 14254 | 0.470 |
Why?
|
| Male | 27 | 2024 | 29487 | 0.460 |
Why?
|
| Spinal Cord Diseases | 4 | 2024 | 39 | 0.460 |
Why?
|
| Prospective Studies | 11 | 2024 | 3258 | 0.420 |
Why?
|
| Thoracic Vertebrae | 3 | 2015 | 33 | 0.420 |
Why?
|
| Spinal Canal | 1 | 2013 | 5 | 0.420 |
Why?
|
| Spinal Cord Compression | 1 | 2013 | 29 | 0.410 |
Why?
|
| Female | 24 | 2024 | 32495 | 0.400 |
Why?
|
| Spinal Cord Injuries | 1 | 2013 | 49 | 0.400 |
Why?
|
| Hyperlipidemias | 1 | 2012 | 34 | 0.390 |
Why?
|
| Orthopedics | 1 | 2012 | 29 | 0.380 |
Why?
|
| Intervertebral Disc Degeneration | 1 | 2011 | 16 | 0.370 |
Why?
|
| Dura Mater | 1 | 2011 | 34 | 0.370 |
Why?
|
| Oligodendroglioma | 2 | 2009 | 7 | 0.360 |
Why?
|
| Lung Diseases | 1 | 2012 | 175 | 0.340 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2011 | 108 | 0.340 |
Why?
|
| Neuroma, Acoustic | 1 | 2010 | 13 | 0.340 |
Why?
|
| Retrospective Studies | 9 | 2024 | 6533 | 0.320 |
Why?
|
| Laminectomy | 2 | 2021 | 21 | 0.310 |
Why?
|
| Adult | 14 | 2024 | 16629 | 0.300 |
Why?
|
| Loss of Heterozygosity | 2 | 2009 | 24 | 0.300 |
Why?
|
| Reoperation | 4 | 2019 | 290 | 0.300 |
Why?
|
| Follow-Up Studies | 10 | 2021 | 2445 | 0.290 |
Why?
|
| Pneumocephalus | 1 | 2008 | 8 | 0.290 |
Why?
|
| Decision Support Techniques | 1 | 2010 | 194 | 0.290 |
Why?
|
| Monitoring, Intraoperative | 2 | 2012 | 45 | 0.290 |
Why?
|
| Rhinitis | 1 | 2008 | 24 | 0.290 |
Why?
|
| Sinusitis | 1 | 2008 | 30 | 0.290 |
Why?
|
| Brain Neoplasms | 2 | 2009 | 308 | 0.280 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2009 | 185 | 0.280 |
Why?
|
| Endoscopy | 1 | 2008 | 108 | 0.270 |
Why?
|
| Ultrasonography, Doppler | 1 | 2006 | 27 | 0.270 |
Why?
|
| Hypertension | 1 | 2012 | 590 | 0.260 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2006 | 24 | 0.260 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 5403 | 0.260 |
Why?
|
| Calcinosis | 1 | 2006 | 83 | 0.250 |
Why?
|
| Laminoplasty | 1 | 2024 | 3 | 0.230 |
Why?
|
| Return to Work | 1 | 2024 | 25 | 0.220 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2016 | 63 | 0.220 |
Why?
|
| Neck | 1 | 2023 | 46 | 0.200 |
Why?
|
| Pedicle Screws | 1 | 2022 | 3 | 0.200 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 137 | 0.190 |
Why?
|
| Outpatients | 1 | 2022 | 141 | 0.190 |
Why?
|
| Comorbidity | 3 | 2015 | 1118 | 0.180 |
Why?
|
| Registries | 2 | 2015 | 872 | 0.170 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 1541 | 0.170 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 66 | 0.160 |
Why?
|
| Societies, Medical | 1 | 2022 | 366 | 0.160 |
Why?
|
| Clinical Trials, Phase IV as Topic | 1 | 2019 | 2 | 0.160 |
Why?
|
| Blood Volume | 2 | 2011 | 42 | 0.160 |
Why?
|
| Product Surveillance, Postmarketing | 1 | 2019 | 21 | 0.160 |
Why?
|
| Health Status | 2 | 2019 | 433 | 0.160 |
Why?
|
| Radiography | 3 | 2021 | 536 | 0.160 |
Why?
|
| Inappropriate Prescribing | 1 | 2019 | 65 | 0.160 |
Why?
|
| Predictive Value of Tests | 2 | 2015 | 1077 | 0.150 |
Why?
|
| Propensity Score | 1 | 2019 | 154 | 0.150 |
Why?
|
| Preoperative Care | 1 | 2019 | 188 | 0.150 |
Why?
|
| Radiology | 1 | 2022 | 248 | 0.150 |
Why?
|
| United States | 5 | 2022 | 7721 | 0.150 |
Why?
|
| Pain, Postoperative | 1 | 2019 | 161 | 0.150 |
Why?
|
| Arachnoid Cysts | 1 | 2016 | 5 | 0.130 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2016 | 5 | 0.130 |
Why?
|
| Bone Transplantation | 2 | 2016 | 29 | 0.130 |
Why?
|
| Jehovah's Witnesses | 1 | 2016 | 18 | 0.130 |
Why?
|
| Craniotomy | 2 | 2016 | 20 | 0.130 |
Why?
|
| Pain | 1 | 2019 | 406 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2016 | 48 | 0.120 |
Why?
|
| Brain Diseases | 1 | 2016 | 75 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2016 | 158 | 0.120 |
Why?
|
| Incidence | 3 | 2015 | 1367 | 0.120 |
Why?
|
| Intraoperative Complications | 1 | 2015 | 89 | 0.110 |
Why?
|
| Models, Economic | 1 | 2014 | 44 | 0.110 |
Why?
|
| Medicare | 2 | 2022 | 614 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2021 | 2150 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 2 | 2016 | 725 | 0.110 |
Why?
|
| Patient Satisfaction | 2 | 2016 | 432 | 0.100 |
Why?
|
| Hospital Charges | 1 | 2012 | 23 | 0.100 |
Why?
|
| Arthroplasty | 2 | 2022 | 5 | 0.100 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2012 | 62 | 0.100 |
Why?
|
| Bone Screws | 1 | 2012 | 30 | 0.100 |
Why?
|
| Decompressive Craniectomy | 1 | 2012 | 5 | 0.100 |
Why?
|
| Glasgow Outcome Scale | 1 | 2012 | 17 | 0.100 |
Why?
|
| Intracranial Pressure | 1 | 2012 | 19 | 0.100 |
Why?
|
| Constriction, Pathologic | 2 | 2022 | 120 | 0.100 |
Why?
|
| Glasgow Coma Scale | 1 | 2012 | 46 | 0.100 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2012 | 42 | 0.100 |
Why?
|
| Erythrocyte Count | 1 | 2011 | 15 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2013 | 161 | 0.100 |
Why?
|
| Diagnosis-Related Groups | 1 | 2012 | 86 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2012 | 90 | 0.090 |
Why?
|
| Cerebrospinal Fluid | 1 | 2011 | 23 | 0.090 |
Why?
|
| Bone Plates | 1 | 2011 | 31 | 0.090 |
Why?
|
| Tumor Burden | 2 | 2011 | 67 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2011 | 5 | 0.090 |
Why?
|
| Orthopedic Fixation Devices | 1 | 2011 | 2 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 2011 | 13 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2011 | 14 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 192 | 0.090 |
Why?
|
| Monitoring, Physiologic | 1 | 2012 | 151 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2011 | 58 | 0.090 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 104 | 0.090 |
Why?
|
| Tinnitus | 1 | 2010 | 19 | 0.080 |
Why?
|
| Watchful Waiting | 1 | 2010 | 27 | 0.080 |
Why?
|
| Microsurgery | 1 | 2010 | 51 | 0.080 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 933 | 0.080 |
Why?
|
| Fractures, Bone | 1 | 2011 | 142 | 0.080 |
Why?
|
| Accidents, Traffic | 2 | 2011 | 152 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 220 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2010 | 62 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2009 | 17 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2009 | 23 | 0.080 |
Why?
|
| Hearing Loss | 1 | 2010 | 61 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2009 | 114 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 2009 | 140 | 0.070 |
Why?
|
| Patient Care Team | 1 | 2011 | 337 | 0.070 |
Why?
|
| Young Adult | 3 | 2015 | 4633 | 0.070 |
Why?
|
| Skull Base | 1 | 2008 | 14 | 0.070 |
Why?
|
| Age Factors | 1 | 2012 | 1554 | 0.070 |
Why?
|
| Vertebral Artery | 1 | 2006 | 28 | 0.070 |
Why?
|
| Demography | 2 | 2016 | 172 | 0.060 |
Why?
|
| Cerebral Angiography | 1 | 2006 | 290 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2008 | 748 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 2174 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2006 | 257 | 0.050 |
Why?
|
| Risk Factors | 2 | 2015 | 5303 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2022 | 5 | 0.050 |
Why?
|
| Back Pain | 1 | 2022 | 50 | 0.050 |
Why?
|
| Triage | 1 | 2022 | 115 | 0.050 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2022 | 122 | 0.050 |
Why?
|
| Dendritic Cells | 1 | 2004 | 523 | 0.050 |
Why?
|
| New England | 1 | 2022 | 272 | 0.050 |
Why?
|
| History, 21st Century | 1 | 2022 | 168 | 0.050 |
Why?
|
| History, 20th Century | 1 | 2022 | 229 | 0.040 |
Why?
|
| Leadership | 1 | 2022 | 203 | 0.040 |
Why?
|
| Spinal Cord | 1 | 2021 | 204 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 716 | 0.040 |
Why?
|
| Referral and Consultation | 1 | 2022 | 422 | 0.040 |
Why?
|
| HIV Infections | 1 | 2004 | 962 | 0.030 |
Why?
|
| Surveys and Questionnaires | 2 | 2016 | 2648 | 0.030 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 14 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2016 | 62 | 0.030 |
Why?
|
| Ohio | 1 | 2016 | 24 | 0.030 |
Why?
|
| Decision Trees | 1 | 2016 | 51 | 0.030 |
Why?
|
| Computed Tomography Angiography | 1 | 2016 | 123 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2016 | 135 | 0.030 |
Why?
|
| Perioperative Period | 1 | 2015 | 20 | 0.030 |
Why?
|
| Pain Measurement | 1 | 2016 | 343 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 277 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 53 | 0.030 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 137 | 0.030 |
Why?
|
| Patient Selection | 1 | 2016 | 482 | 0.030 |
Why?
|
| Animals | 1 | 2011 | 20584 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2011 | 1589 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2016 | 1110 | 0.030 |
Why?
|
| Adolescent | 2 | 2015 | 6172 | 0.030 |
Why?
|
| Lumbosacral Region | 1 | 2012 | 20 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2016 | 989 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2016 | 729 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 458 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2015 | 852 | 0.020 |
Why?
|
| Atlanto-Axial Joint | 1 | 2011 | 3 | 0.020 |
Why?
|
| Child Restraint Systems | 1 | 2011 | 5 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 2011 | 52 | 0.020 |
Why?
|
| Thoracoscopy | 1 | 2011 | 25 | 0.020 |
Why?
|
| Research Design | 1 | 2014 | 572 | 0.020 |
Why?
|
| Congenital Abnormalities | 1 | 2011 | 26 | 0.020 |
Why?
|
| Fracture Fixation | 1 | 2011 | 17 | 0.020 |
Why?
|
| Fluoroscopy | 1 | 2011 | 64 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2011 | 46 | 0.020 |
Why?
|
| Neoplasm, Residual | 1 | 2011 | 42 | 0.020 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2011 | 35 | 0.020 |
Why?
|
| Neoadjuvant Therapy | 1 | 2011 | 82 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 370 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 430 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2009 | 168 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2014 | 2540 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 544 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2011 | 667 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2009 | 502 | 0.020 |
Why?
|
| Cytopathogenic Effect, Viral | 1 | 2004 | 11 | 0.010 |
Why?
|
| Giant Cells | 1 | 2004 | 15 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2004 | 157 | 0.010 |
Why?
|
| Plasma Cells | 1 | 2004 | 52 | 0.010 |
Why?
|
| Virulence | 1 | 2004 | 195 | 0.010 |
Why?
|
| Interferon-alpha | 1 | 2004 | 102 | 0.010 |
Why?
|
| Antibodies | 1 | 2004 | 182 | 0.010 |
Why?
|
| Cell Death | 1 | 2004 | 280 | 0.010 |
Why?
|
| Virus Replication | 1 | 2004 | 318 | 0.010 |
Why?
|
| Child | 1 | 2011 | 4444 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2004 | 2154 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 1346 | 0.010 |
Why?
|